New Age Farm Inc.’s (NF: CNX) subsidiary, NHS Industries Ltd., has filed and obtained a receipt for its preliminary non-offering prospectus with the British Columbia Securities Commission. The preliminary prospectus contains important information relating to NHS and its currently issued securities and is subject to amendment as may be required by the BCSC. Copies of the preliminary prospectus are available on SEDAR at http://www.sedar.com under NHS’ SEDAR profile. NHS is the subject of a plan of arrangement with the Company whereby NHS will spin out from the Company to become an independently operated company and reporting issuer that will list its common shares on the Canadian Securities Exchange (the “CSE”). The preliminary prospectus is the first step in this listing process. NHS will now submit its listing application to the CSE and has reserved the trading symbol “NHS” for its common shares. More information regarding the Company and the plan of arrangement with NHS can be found in the Company’s disclosure record on SEDAR.

NHS is an agricultural services company based in Langley, BC focused on providing turnkey agricultural services at its fully Agricultural Land Reserve-approved location to entry level agricultural businesses seeking a location where they can take their product from seed to sale. NHS will offer value added services to offsite growers who wish to increase potential revenues from small scale agricultural operations. There is a significant trend toward local, clean-label food and NHS is positioned to assist growers in achieving maximum potential from their crops whether grown on the Langley site or grown off-site and brought in for further processing, storage and distribution. The entry barriers to becoming a grower are high. NHS aims to minimize the initial start-up costs for new growers by providing turnkey solutions that allow a tenant grower on its site to arrive, flip a switch and start farming. For growers who may have a small scale agricultural operation off-site, there are infrastructure, personnel and regulatory costs associated with creating a value added product from their crops. In a business with high overhead and tight margins, there may not be cash available to build on this infrastructure to get this aspect of their business underway. By providing everything the small-scale operator needs under one umbrella, NHS can help them increase the value of the crops by turning them into marketable products thereby allowing the operator to get the maximum income from its operations.

Update to Plan of Arrangement

The filing of the preliminary prospectus is the first step in qualifying the NHS Shares for trading on a stock exchange. Once the BCSC has reviewed the preliminary prospectus and provided their commentary, NHS will respond and update the prospectus until such time as the BCSC accepts it as final. This process will take several weeks, after which time the NHS Shares will be ready to be listed for trading on the CSE. Until such time, New Age Farm continues to hold the NHS Shares in trust for the New Age Farm shareholders who are qualified to receive NHS Shares as of the Share Distribution Record Date (see New Age Farm news releases dated September 22, November 10 and December 5, 2016). The Company has prepared a series of FAQ’s for shareholders who are seeking more information on the Plan of Arrangement and the distribution of the NHS Shares, which can be found on its website at http://newagefarminc.com/investors/nhs-faqs/ .

Carman Parente, president and CEO of New Age Farm commented, “The Company understands that shareholders are eager to receive their NHS Shares, and we are undertaking all steps required to have the NHS Shares issued to shareholders in as timely manner as possible, while taking into account that until NHS is listed on a stock exchange, there is no market for the shares. Therefore, the Company and NHS are working toward the listing event as a very significant milestone and a high priority so that we can bring this new value to shareholders. We look forward to working with the CSE to list the NHS Shares on the exchange.”

In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.